President Jokowi was the first person to receive covid-19 vaccine in Indonesia.
"That did not hurt at all," the President said after getting the jab.
Last week, The Food and Drugs Monitoring Agency (BPOM) officially issued the EUA (Emergency Use Authorization) for CoronaVac, a COVID-19 vaccine developed by China’s Sinovac Biotech.
According to the agency, the side effects of the covid-19 vaccine are not dangerous.
Meanwhile, an analysis of the efficacy of CoronaVac from phase three clinical trials shows that the vaccine has met the WHO’s requirement of a minimum 50 percent efficacy.
The results of clinical trial in Bandung demonstrate a 65.3 percent efficacy, while similar trial in Turkey demonstrates a 91.25 percent efficacy, and 78 percent for trial in Brazil.